Didronel
Didronel

1.21
For patients managing bone health, this generic medicine aids in mineral regulation to slow the breakdown of bone density and address structural integrity.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Etidronate disodium
Reference Brand
Etidronate
Product Origin
Generic Alternative
Reference Manufacturer
Procter & Gamble Pharmaceuticals
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones
Product Category
Bisphosphonate
Pharmacological Class
Bone Resorption Inhibitor
Manufacturer Description
Utilized to manage abnormal bone turnover to alleviate skeletal pain and support structural bone preservation.
Mechanism of Action
Binds to calcium phosphate crystals in bone tissue, slowing down osteoclast-mediated resorption and heterotopic mineralization.
Route of Administration
Oral
Onset Time
1–3 months
Duration
12–24 hours
Contraindications
Severe renal impairment, Hypersensitivity to etidronate
Severe Adverse Events
Osteonecrosis of the jaw — requires immediate medical attention, Severe hypocalcemia — requires immediate medical attention
Common Side Effects
Dyspepsia, Nausea, Abdominal pain
Uncommon Side Effects
Bone pain, Diarrhea, Headache
Drug Interactions
Calcium Supplements, Antacids
Pregnancy Safety Warnings
TGA Category C: Use if potential therapeutic benefit justifies fetal risks. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Didronel is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to order Sleep Aid Tablets - Circadin Australia